• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Eleclazine hydrochloride

CAS No. 1448754-43-5

Eleclazine hydrochloride ( GS-6615 hydrochloride )

产品货号. M11926 CAS No. 1448754-43-5

一种新型、强效、选择性的晚钠电流 (late INa) 抑制剂,用于治疗长 QT-3 综合征 (LQT-3)。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1121 有现货
10MG ¥1691 有现货
25MG ¥2725 有现货
50MG ¥3887 有现货
100MG ¥5067 有现货
200MG ¥6831 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥1131 有现货

生物学信息

  • 产品名称
    Eleclazine hydrochloride
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    一种新型、强效、选择性的晚钠电流 (late INa) 抑制剂,用于治疗长 QT-3 综合征 (LQT-3)。
  • 产品描述
    A novel, potent, and selective inhibitor of Late sodium current (late INa) for treatment of long QT-3 syndrome (LQT-3), hypertrophic cardiomyopathy (HCM), and ventricular tachycardia–ventricular fibrillation (VT–VF); 42 times more potent than Ranolazine in reducing ischemic burden in vivo (EC50=190 nM).Heart Arrhythmia Phase 3 Clinical(In Vitro):Eleclazine inhibits sodium current in hiPSC-derived cardiomyocytes with an IC50 of 2.5 μM.(In Vivo):Eleclazine (0.3 and 0.9 mg/kg; IV; infused over 15 minutes) reduces the incidence of epinephrine-induced ventricular premature beats and couplets, and shortens ventricular QT and atrial PTa intervals.
  • 体外实验
    Eleclazine inhibits sodium current in hiPSC-derived cardiomyocytes with an IC50 of 2.5 μM.
  • 体内实验
    Eleclazine (0.3 and 0.9 mg/kg; IV; infused over 15 minutes) reduces the incidence of epinephrine-induced ventricular premature beats and couplets, and shortens ventricular QT and atrial PTa intervals. Animal Model:Male Yorkshire pigs (35.20 ± 0.46 kg; injected with epinephrine via a jugular vein)Dosage:0.3 and 0.9 mg/kg Administration:IV; infused over 15 minutes Result:Reduced the incidence of epinephrine-induced ventricular premature beats and couplets by 51% (from 31.3 ± 1.91 to 15.2 ± 5.08 episodes; P = 0.038) and the incidence of 3- to 7-beat ventricular tachycardia (VT) by 56% (from 10.8 ± 3.45 to 4.7 ± 3.12 episodes; P = 0.004).Shortened ventricular QT and atrial PTa intervals by 7%, and reduced atrial repolarization alternans and heterogeneity without attenuation of the inotropic response to catecholamine.
  • 同义词
    GS-6615 hydrochloride
  • 通路
    Membrane Transporter/Ion Channel
  • 靶点
    Sodium Channel
  • 受体
    Sodium Channel
  • 研究领域
    Cardiovascular Disease
  • 适应症
    Heart Arrhythmia

化学信息

  • CAS Number
    1448754-43-5
  • 分子量
    451.8262
  • 分子式
    C21H17ClF3N3O3
  • 纯度
    >98% (HPLC)
  • 溶解度
    10 mM in DMSO
  • SMILES
    O=C1N(CC2=NC=CC=N2)CCOC3=CC=C(C4=CC=C(OC(F)(F)F)C=C4)C=C13.[H]Cl
  • 化学全称
    1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl]-, hydrochloride (1:1)

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Zablocki JA, et al. J. Med. Chem., 2016, 59 (19), pp 9005–90172. Fuller H, et al. Heart Rhythm. 2016 Aug;13(8):1679-86. 3. Bacic D, et al. Heart Rhythm. 2017 Mar;14(3):448-454.
产品手册
关联产品
  • Phenytoin

    Phenytoin (5,5-Diphenylhydantoin) 是一种有效的电压门控 Na+ 通道 (VGSCs) 阻滞剂。Phenytoin 具有抗癫痫活性,也可减少小鼠乳腺肿瘤的生长和转移。

  • BI-9627

    BI-9627 是一种钠氢交换异构体 1 (NHE1) 抑制剂,在细胞内 pH 恢复 (pHi) 和人血小板溶胀试验中 IC50 值为 6 和 31 nM。BI-9627 对 NHE2 的选择性大于 30 倍,对 NHE3 没有明显的抑制活性。BI-9627 表现出较低的 DDI (活性分子-活性分子相互作用) 潜力,在大鼠和犬体内良好的药代动力学,在离体心脏缺血-再灌注损伤模型中表现出显著的活性。

  • Ambroxol hydrochlori...

    Ambroxol HCl 是神经元 Na+ 通道的有效抑制剂,抑制 TTX 抗性 Na+ 电流,IC50 为 35.2 μM,对于强直和相位阻滞,IC50 为 35.2 μM,IC50 为 22.5 μM。